Doctor, meet Mona: Clinomic scores €23 million to upgrade ICU care

Aachen-based HealthTech startup Clinomic has secured a €23 million in Series B funding to accelerate the deployment of its AI-driven intensive care unit (ICU) assistant, Mona, and expand into global markets with its healthcare solutions.

The round was co-led by DeepTech & Climate Fonds (DTCF) and a private family office, bringing the total funding to €44.8 million.

Co-founders Dr Arne Peine and Dr Lukas Martin comment: “As medical doctors working on the ICU, we experience it every day: Data density in high-acuity settings is increasing, leaving us less and less time for the patient.

“We need revolutionary new approaches to deliver optimal patient care. Good future care will only be possible if we close existing digitisation gaps and consolidate all relevant data in one place. That’s why we’re building the ‘iPhone for the ICU’.”

Founded in 2019 by intensive care physicians from RWTH Aachen University Hospital, Clinomic developed Mona to streamline ICU workflows by consolidating, analysing, and visualising patient and operational data in real-time. This platform aims to improve patient outcomes, enhance workflow efficiency, and reduce costs for hospitals.

Clinomic plans to use the new capital to expand its international presence, enhance its AI and data capabilities, and deepen its impact on critical care delivery. The company employs over 70 professionals, including engineers, developers, data scientists, and doctors, dedicated to improving patient and provider care.

Georg Griesemann, CEO, Clinomic, says, “It is a great honor to have such strong partners on board who share our vision of transforming critical care. Their support enables us to accelerate our business even faster.

“As we look to the future, we remain committed to tackling the most pressing challenges in intensive care – from staff shortages and information overload to digitisation gaps. Mona lays the foundation for modern, data-driven intensive care, empowering clinicians and improving lives.”

Mona, short for Medical On-Site Assistant, integrates technologies such as AI, speech recognition, and telemedicine. It aggregates patient information from various hospital departments, processes this data to deliver actionable insights, and responds to voice commands, reducing the need for physical contact with devices. Mona also facilitates remote consultations and features predictive analytics to flag critical changes in patient data.

The platform has been implemented in over 40 hospitals across eight EU countries and is seeking FDA approval for U.S. market expansion.

Günther Bogenrieder, Investment Manager at DTCF, added: “From our very first conversations, we saw how Clinomic is using AI to solve critical healthcare challenges with real, measurable impact. Georg, Arne, Lukas, and their exceptional team are redefining intensive care.

“The Mona platform is significantly improving quality of patient care, while reducing healthcare costs by making all relevant data accessible in one platform and thus optimizing clinical and administrative workflows. These results prove that Clinomic is setting a new global standard for digital intensive care.”

The post Doctor, meet Mona: Clinomic scores €23 million to upgrade ICU care appeared first on EU-Startups.